These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 9788519

  • 21. Urine drug-testing tampering approaches: Turkish probationers.
    Aydoğdu M, Akgür SA.
    Med Sci Law; 2021 Jan; 61(1):6-13. PubMed ID: 32924786
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Validity testing of the EZ-SCREEN cannabinoid test.
    Jenkins AJ, Mills LC, Darwin WD, Huestis MA, Cone EJ, Mitchell JM.
    J Anal Toxicol; 1993 Sep; 17(5):292-8. PubMed ID: 8107464
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use.
    Musshoff F, Madea B.
    Ther Drug Monit; 2006 Apr; 28(2):155-63. PubMed ID: 16628124
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Excretion profile of opiates in dependent patients in relation to route of administration and type of drug measured in urine with immunoassay.
    Taracha E, Habrat B, Chmielewska K, Baran-Furga H.
    J Anal Toxicol; 2005 Apr; 29(1):15-21. PubMed ID: 15808008
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Drug and chemical metabolites in clinical toxicology investigations: the importance of ethylene glycol, methanol and cannabinoid metabolite analyses.
    Fraser AD, Coffin L, Worth D.
    Clin Biochem; 2002 Oct; 35(7):501-11. PubMed ID: 12493577
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial.
    Tomko RL, Baker NL, McClure EA, Sonne SC, McRae-Clark AL, Sherman BJ, Gray KM.
    Drug Alcohol Depend; 2018 Jan 01; 182():1-7. PubMed ID: 29112827
    [Abstract] [Full Text] [Related]

  • 33. Creatinine excretion in consecutive urine samples after controlled ingestion of water.
    Franz S, Skopp G, Boettcher M, Musshoff F.
    Drug Test Anal; 2019 Mar 01; 11(3):435-440. PubMed ID: 30276981
    [Abstract] [Full Text] [Related]

  • 34. ACMT Position Statement: Interpretation of Urine for Tetrahydrocannabinol Metabolites.
    Connors N, Kosnett MJ, Kulig K, Nelson LS, Stolbach AI.
    J Med Toxicol; 2020 Apr 01; 16(2):240-242. PubMed ID: 31939053
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Marijuana abstinence effects in marijuana smokers maintained in their home environment.
    Budney AJ, Hughes JR, Moore BA, Novy PL.
    Arch Gen Psychiatry; 2001 Oct 01; 58(10):917-24. PubMed ID: 11576029
    [Abstract] [Full Text] [Related]

  • 37. Interpretation of urine quantitative 11-nor-delta-9 tetrahydrocannabinol-9-carboxylic acid to determine abstinence from marijuana smoking.
    Bell R, Taylor EH, Ackerman B, Pappas AA.
    J Toxicol Clin Toxicol; 1989 Oct 01; 27(1-2):109-15. PubMed ID: 2549268
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Laboratory detection of marijuana use. Experience with a photometric immunoassay to measure urinary cannabinoids.
    Schwartz RH, Hayden GF, Riddile M.
    Am J Dis Child; 1985 Nov 01; 139(11):1093-6. PubMed ID: 3904404
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.